JAMES A. JOYCE - Corporate Board Profile

AETHLON MEDICAL INC

Filing Date	Source Excerpt
2005-05-09	James A. Joyce, Chairman and CEO 1,965,550 shares(4) 10.5% 3030 Bunker Hill Street, Suite 4000, San Diego, CA 92109
2007-02-09	Mr. Joyce is the founder of Aethlon Medical, and has been the Chairman of the Board and Secretary since March 1999. On June 1, 2001, our Board of Directors appointed Mr. Joyce with the additional role of CEO.
2009-08-04	Mr. Joyce (age 46) is the founder of Aethlon Medical, and has been the Chairman of the Board and Secretary of the Company since March 1999. On June 1, 2001, our Board of Directors appointed Mr. Joyce to the additional positions of President and CEO. During the quarter ended December 31, 2007, our Chief Financial Officer resigned and Mr. Joyce assumed the role of Principal Accounting Officer.
2012-04-20	James A. Joyce Chairman & CEO ... /s/ James A. Joyce James A. Joyce Chairman & CEO
2016-02-23	James A. Joyce (1) Chairman, Chief Executive Officer and Secretary 53 ... Mr. Joyce is the founder of Aethlon Medical, Inc. and has been the Chairman of the Board and Secretary since March 1999. On June 1, 2001, our Board of Directors appointed Mr. Joyce to the additional role of Chief Executive Officer. ... Mr. Joyce received a $5,000 salary increase from $325,000 to $330,000 effective July 1, 2013. In June 2014, Mr. Joyce received a $20,000 salary increase from $330,000 to $350,000. ... SUMMARY COMPENSATION TABLE FOR 2015 ... James A. Joyce (1) 2015 ... TOTAL ($) 688,500 ... Director Compensation for 2015 Fiscal Year ... (1) All compensation received by Mr. Joyce in fiscal year 2015 is disclosed in the Summary Compensation Table above. Mr. Joyce received no compensation as a director in fiscal year 2015.
2017-02-13	The four nominees selected by the Board of Directors are listed below. Each of the nominees must receive the vote of a majority of a quorum present at the meeting to be elected. Any shares not voted, whether by abstention, broker non-vote, or otherwise, have no impact on the vote. The proxy holders intend to vote proxies equally for the nominees unless otherwise instructed on the proxy card. If you do not wish your shares to be voted for particular nominees, please identify the exceptions in the designated space provided on the proxy card. If at the time of the meeting one or more of the nominees have become unavailable to serve, shares represented by proxies will be voted for the remaining nominees and for any substitute nominee or nominees designated by the Board of Directors. All of the nominees are currently directors of our company. All of the nominees have consented to serve if elected. The Board of Directors has no reason to anticipate that any of the nominees will not be able to serve, if elected. Although we are authorized to have a board consisting of nine directors, only four nominees, our incumbent directors, have been named below. We believe the current number of directors is appropriate given our stage of development. Directors elected at the meeting will hold office until the next Annual Meeting of Stockholders or until their successors have been elected and qualified. Listed below are the nominees for the Board of Directors. Please see “Information About Our Board of Directors and Executive Officers” for additional information concerning the individuals named below, which is based on information furnished to us by each individual noted. Nominee Age Position James A. Joyce 55 Chairman, Chief Executive Officer and Secretary
2018-02-16	James A. Joyce (1) Chief Executive Officer and Secretary 55; Summary Compensation Table for 2017 and 2016 Fiscal Years; James A. Joyce (1) 2017 Salary $385,000, Total $1,063,380; Director Compensation for 2017 Fiscal Year: James A. Joyce (1) All compensation received by Mr. Joyce in fiscal year 2017 is disclosed in the Summary Compensation Table above. Mr. Joyce received no compensation as a director in fiscal year 2017.